⚠ Novel chemotype — no close known analogue (best Tanimoto < 0.3). Unexplored chemical space relative to ChEMBL.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| Butyric Acid SCHEMBL7879075 | 1.00 | FFAR3 (0.93) | — | |
| Butyric Acid SCHEMBL358880 | 1.00 | — | — | |
| Butyric Acid SCHEMBL27823458 | 1.00 | FFAR3 (0.93) | — | |
| Butyric Acid SCHEMBL28462096 | 1.00 | FFAR3 (0.93) | — | |
| Butyric Acid SCHEMBL28041240 | 0.97 | — | — | |
| Butyric Acid SCHEMBL29930560 | 0.97 | — | — | |
| Butyric Acid SCHEMBL4781139 | 0.97 | — | — | |
| Butyric Acid SCHEMBL27991599 | 0.97 | FFAR3 (0.87) | — | |
| Butyric Acid SCHEMBL1017693 | 0.97 | — | — | |
| Butyric Acid SCHEMBL4344262 | 0.97 | — | — |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 38 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-11147872-B2 | Multivalent glycoconjugate vaccines | BIOSYNTH S.R.L. (IT) | 2021-10-19 | — | — | US | claimed |
| CN-106659799-B | Glycoconjugate vaccines comprising a basic unit of a molecular construct expressing a built-in plurality of epitopes for the preparation of a broad spectrum vaccine against infections caused by enteropathogenic bacteria | 碧奥辛斯有限责任公司 | 2020-07-17 | — | — | CN | claimed |
| CN-104955476-B | Multivalent glycoconjugate vaccines | 碧奥辛斯有限责任公司 | 2020-06-16 | — | — | CN | claimed |
| US-20190224310-A1 | MULTIVALENT GLYCOCONJUGATE VACCINES | BIOSYNTH S.R.L. (IT) | 2019-07-25 | — | — | US | claimed |
| EP-2950815-B1 | MULTIVALENT GLYCOCONJUGATE VACCINES | BIOSYNTH SRL (IT) | 2018-04-18 | — | — | EP | claimed |
| EP-3174553-B1 | GLYCOCONJUGATE VACCINES COMPRISING BASIC UNITS OF A MOLECULAR CONSTRUCT EXPRESSING MULTIPLE BUILT-IN EPITOPES FOR THE FORMULATION OF A BROAD-SPECTRUM VACCINE AGAINST INFECTIONS DUE TO ENTEROPATHOGENIC BACTERIA | BIOSYNTH SRL (IT) | 2018-04-18 | — | — | EP | claimed |
| US-20170209563-A1 | GLYCOCONJUGATE VACCINES COMPRISING BASIC UNITS OF A MOLECULAR CONSTRUCT EXPRESSING BUILT-IN MULTIPLE EPITOPES FOR THE FORMULATION OF A BROAD-SPECTRUM VACCINE AGAINST INFECTIONS DUE TO ENTEROPATHOGENIC BACTERIA | BIOSYNTH S.R.L. (IT) | 2017-07-27 | — | — | US | claimed |
| EP-3174553-A1 | GLYCOCONJUGATE VACCINES COMPRISING BASIC UNITS OF A MOLECULAR CONSTRUCT EXPRESSING BUILT-IN MULTIPLE EPITOPES FOR THE FORMULATION OF A BROAD-SPECTRUM VACCINE AGAINST INFECTIONS DUE TO ENTEROPATHOGENIC BACTERIA | BIOSYNTH S.R.L. (IT) | 2017-06-07 | — | — | EP | claimed |
| US-20170143821-A1 | MULTIVALENT GLYCOCONJUGATE VACCINES | BIOSYNTH S.R. L. (IT) | 2017-05-25 | — | — | US | claimed |
| WO-2016012587-A1 | GLYCOCONJUGATE VACCINES COMPRISING BASIC UNITS OF A MOLECULAR CONSTRUCT EXPRESSING BUILT-IN MULTIPLE EPITOPES FOR THE FORMULATION OF A BROAD-SPECTRUM VACCINE AGAINST INFECTIONS DUE TO ENTEROPATHOGENIC BACTERIA | BIOSYNTH S.R.L. (IT) | 2016-01-28 | — | — | WO | claimed |
| EP-2950815-A1 | MULTIVALENT GLYCOCONJUGATE VACCINES | BIOSYNTH S.R.L. (IT) | 2015-12-09 | — | — | EP | claimed |
| WO-2014118201-A1 | MULTIVALENT GLYCOCONJUGATE VACCINES | BIOSYNTH S.R.L. (IT) | 2014-08-07 | — | — | WO | claimed |
| US-11576959-B2 | Glycoconjugate vaccines comprising basic units of a molecular construct expressing built-in multiple epitopes for the formulation of a broad-spectrum vaccine against infections due to enteropathogenic bacteria | BIOSYNTH S.R.L. (IT) | 2023-02-14 | — | — | US | disclosed |
| US-11547755-B2 | Multivalent glycoconjugate vaccines | BIOSYNTH S.R.L. (IT) | 2023-01-10 | — | — | US | disclosed |
| US-11246919-B2 | Glycoconjugate vaccines comprising basic units of a molecular construct expressing built-in multiple epitopes for the formulation of a broad-spectrum vaccine against infections due to enteropathogenic bacteria | BIOSYNTH S.R.L. (IT) | 2022-02-15 | — | — | US | disclosed |
| US-11147872-B2 | Multivalent glycoconjugate vaccines | BIOSYNTH S.R.L. (IT) | 2021-10-19 | — | — | US | disclosed |
| EP-2263996-A1 | PROCESS FOR PRODUCING DIAMINE AND POLYAMIDE | Toray Industries, Inc. (JP) | 2010-12-22 | — | — | EP | disclosed |
| EP-0835279-A4 | IMPROVED SURFACE TREATMENT OF POLYMERS | COMMW SCIENT IND RES ORG (AU) | 1999-02-17 | — | — | EP | disclosed |
| EP-0835279-A1 | IMPROVED SURFACE TREATMENT OF POLYMERS | COMMONWEALTH SCIENTIFIC AND INDUSTRIAL RESEARCH ORGANISATION (AU) | 1998-04-15 | — | — | EP | disclosed |
| WO-1997002310-A1 | IMPROVED SURFACE TREATMENT OF POLYMERS | COMMONWEALTH SCIENTIFIC AND INDUSTRIAL RESEARCH ORGANISATION (AU) | 1997-01-23 | — | — | WO | disclosed |